All In Biotech

Drug Trial Radar · NCT06745336

Clinical Study of CS-001 as a Treatment for Canities (Grey Hair)

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Jun 15, 2027

Primary completion

Dec 15, 2027

Study completion Dec 30, 2027

Sponsor

Lead sponsor
Applied Biology, Inc.Industry
Sponsor type
Industry
Collaborators
Complex Science
First posted
Dec 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 30 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)

Conditions

  • Canities
  • Grey Hair

Interventions

  • CS-001Drug

    CS-001 Topical Treatment

  • Placebo Topical SolutionDrug

    Placebo Topical Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Greying Severity ScoreTime frame: Week [0,52]

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.